Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Hidden Gem Report: Intercept Pharma Ready To Explode
Article By:
Gareth Soloway
Tuesday, May 18, 2021 4:13 PM EDT
This biotech company is flying under the radar and could see easily 100% upside in the near-term based on both fundamental and technical signals.
In this article: ICPT
Intercept Downgraded To Sell From Neutral At H.C. Wainwright
Article By:
The Fly
Tuesday, February 23, 2021 8:22 AM EDT
H.C. Wainwright analyst Ed Arce downgraded Intercept Pharmaceuticals to Sell from Neutral with a price target of $25, down from $46, after the company disclosed that its Chief Medical Officer Jason Campagna has decided to resign effective March 5.
In this article: ICPT
Abbvie Earnings Drive Biotech Stocks Higher With Large Caps Dominant
Article By:
Rod Raynovich
Friday, January 26, 2018 6:44 PM EDT
Biotech stocks soared again today to new highs driven by Abbvie Inc. earnings and overall sector strength. Momentum was strong in the general market with NASDAQ up 1.28% and the S&P up 1.18%. The M&A theme should be the driver in 2017.